A. William Tank
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Tyrosine 3-Monooxygenase | 47 | 1981 | 30 |
Why?
| Gene Expression Regulation, Enzymologic | 12 | 1992 | 104 |
Why?
| Adrenal Medulla | 11 | 1991 | 9 |
Why?
| Nicotine | 9 | 1991 | 19 |
Why?
| RNA, Messenger | 22 | 1983 | 394 |
Why?
| Cyclic AMP | 15 | 1981 | 89 |
Why?
| Mesencephalon | 4 | 1998 | 22 |
Why?
| Nicotinic Agonists | 5 | 1998 | 4 |
Why?
| Rats | 41 | 1979 | 530 |
Why?
| Promoter Regions, Genetic | 9 | 1995 | 188 |
Why?
| Transcription, Genetic | 13 | 1991 | 253 |
Why?
| Dopamine | 10 | 1979 | 62 |
Why?
| Pheochromocytoma | 13 | 1983 | 21 |
Why?
| Gene Expression Regulation | 5 | 1995 | 277 |
Why?
| Protein Biosynthesis | 2 | 2008 | 113 |
Why?
| Adrenal Glands | 5 | 1984 | 35 |
Why?
| Cyclic AMP Response Element-Binding Protein | 4 | 1997 | 22 |
Why?
| Locus Coeruleus | 2 | 2004 | 13 |
Why?
| Neurons | 7 | 1990 | 195 |
Why?
| Animals | 52 | 1979 | 1031 |
Why?
| Adrenal Gland Neoplasms | 11 | 1983 | 25 |
Why?
| Rats, Sprague-Dawley | 11 | 1998 | 257 |
Why?
| Tetradecanoylphorbol Acetate | 5 | 1987 | 83 |
Why?
| Receptors, Muscarinic | 3 | 1996 | 16 |
Why?
| Proto-Oncogene Proteins c-fos | 2 | 2002 | 35 |
Why?
| Muscarinic Agonists | 3 | 1998 | 15 |
Why?
| Stress, Physiological | 3 | 1984 | 76 |
Why?
| Dexamethasone | 9 | 1982 | 109 |
Why?
| 3' Untranslated Regions | 1 | 2009 | 21 |
Why?
| Stress, Psychological | 3 | 1999 | 117 |
Why?
| RNA Processing, Post-Transcriptional | 2 | 1992 | 33 |
Why?
| Pyrimidines | 1 | 2009 | 49 |
Why?
| Glucocorticoids | 5 | 1982 | 107 |
Why?
| Hormone Antagonists | 1 | 2009 | 26 |
Why?
| Mifepristone | 1 | 2009 | 30 |
Why?
| Enzyme Induction | 10 | 1981 | 64 |
Why?
| PC12 Cells | 8 | 1992 | 27 |
Why?
| Receptors, Nicotinic | 2 | 1991 | 15 |
Why?
| Transcriptional Activation | 2 | 1999 | 99 |
Why?
| Cold Temperature | 4 | 1985 | 59 |
Why?
| RNA, Antisense | 2 | 1999 | 11 |
Why?
| Phorbol Esters | 1 | 2003 | 12 |
Why?
| Forskolin | 7 | 1986 | 19 |
Why?
| Mice | 13 | 1981 | 623 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 1999 | 62 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2004 | 243 |
Why?
| Male | 23 | 1979 | 1553 |
Why?
| Aging | 3 | 1990 | 275 |
Why?
| Atropine | 2 | 1996 | 25 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 1996 | 126 |
Why?
| Time Factors | 10 | 1982 | 896 |
Why?
| Synapses | 2 | 1998 | 49 |
Why?
| Substantia Nigra | 5 | 1990 | 30 |
Why?
| Chloramphenicol O-Acetyltransferase | 4 | 1996 | 21 |
Why?
| Amphetamine | 1 | 1998 | 11 |
Why?
| Dopamine Uptake Inhibitors | 1 | 1998 | 7 |
Why?
| Response Elements | 1 | 1998 | 40 |
Why?
| Nerve Degeneration | 1 | 1998 | 43 |
Why?
| Transfection | 4 | 1999 | 237 |
Why?
| Restraint, Physical | 3 | 1999 | 20 |
Why?
| Tumor Cells, Cultured | 6 | 1992 | 233 |
Why?
| Bethanechol | 3 | 1998 | 2 |
Why?
| Sympathetic Nervous System | 1 | 1998 | 43 |
Why?
| Calcium | 3 | 1996 | 208 |
Why?
| Cell Communication | 2 | 1994 | 72 |
Why?
| Neuroblastoma | 3 | 1981 | 36 |
Why?
| Splanchnic Nerves | 3 | 1991 | 3 |
Why?
| Nicotinic Antagonists | 3 | 1991 | 3 |
Why?
| Denervation | 3 | 1998 | 19 |
Why?
| Enzyme Activation | 7 | 1984 | 177 |
Why?
| Kinetics | 7 | 1981 | 349 |
Why?
| Analysis of Variance | 3 | 2004 | 339 |
Why?
| Base Sequence | 4 | 1995 | 371 |
Why?
| Carbachol | 3 | 1981 | 30 |
Why?
| Phosphorylation | 9 | 1984 | 224 |
Why?
| Drug Administration Schedule | 3 | 2000 | 191 |
Why?
| Corpus Striatum | 3 | 1992 | 48 |
Why?
| Dopamine beta-Hydroxylase | 2 | 1999 | 8 |
Why?
| Liver | 3 | 1979 | 248 |
Why?
| Blotting, Western | 3 | 1997 | 275 |
Why?
| Dose-Response Relationship, Drug | 4 | 1982 | 431 |
Why?
| Hexamethonium | 2 | 2001 | 3 |
Why?
| Recombinant Fusion Proteins | 3 | 1996 | 189 |
Why?
| Cell Line | 9 | 1981 | 375 |
Why?
| Parkinson Disease, Secondary | 2 | 2000 | 17 |
Why?
| Potassium Chloride | 2 | 1981 | 42 |
Why?
| Maneb | 2 | 2000 | 4 |
Why?
| Membrane Proteins | 1 | 1997 | 233 |
Why?
| Paraquat | 2 | 2000 | 12 |
Why?
| Molecular Sequence Data | 3 | 1995 | 404 |
Why?
| Rats, Inbred Strains | 7 | 1981 | 170 |
Why?
| Isoenzymes | 2 | 1981 | 144 |
Why?
| Nucleic Acid Hybridization | 2 | 1983 | 94 |
Why?
| Drug Interactions | 3 | 1986 | 111 |
Why?
| 3,4-Dihydroxyphenylacetic Acid | 4 | 1979 | 11 |
Why?
| Aldehyde Dehydrogenase | 2 | 1981 | 4 |
Why?
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2009 | 3 |
Why?
| Mice, Transgenic | 2 | 1997 | 209 |
Why?
| Bone Density | 1 | 2009 | 62 |
Why?
| Bone Remodeling | 1 | 2009 | 33 |
Why?
| Thionucleotides | 2 | 1994 | 15 |
Why?
| Leucine Zippers | 1 | 2008 | 10 |
Why?
| Protein Kinases | 3 | 1984 | 64 |
Why?
| Recombination, Genetic | 1 | 2009 | 78 |
Why?
| Norepinephrine | 2 | 1986 | 68 |
Why?
| Cell Membrane | 2 | 1996 | 170 |
Why?
| Parkinsonian Disorders | 1 | 2008 | 19 |
Why?
| Polyribosomes | 1 | 2007 | 15 |
Why?
| Deoxyglucose | 1 | 2007 | 17 |
Why?
| Antimetabolites | 1 | 2007 | 21 |
Why?
| Animals, Newborn | 1 | 2009 | 175 |
Why?
| Aldehydes | 1 | 1986 | 19 |
Why?
| Cell Line, Tumor | 1 | 2009 | 208 |
Why?
| Ethanol | 3 | 1979 | 58 |
Why?
| Mutagenesis, Site-Directed | 2 | 1996 | 126 |
Why?
| Flavones | 1 | 2005 | 4 |
Why?
| Reserpine | 1 | 1985 | 8 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2008 | 68 |
Why?
| Cells, Cultured | 3 | 1982 | 447 |
Why?
| Alkaline Phosphatase | 1 | 2005 | 59 |
Why?
| Muscarinic Antagonists | 1 | 2004 | 10 |
Why?
| Blotting, Northern | 1 | 2005 | 151 |
Why?
| Mice, Inbred C57BL | 5 | 1990 | 318 |
Why?
| Time | 1 | 2004 | 41 |
Why?
| Models, Genetic | 1 | 2004 | 90 |
Why?
| Neurotoxins | 1 | 2003 | 33 |
Why?
| Injections, Subcutaneous | 1 | 2003 | 63 |
Why?
| Clone Cells | 1 | 2003 | 92 |
Why?
| Mutation | 1 | 2009 | 340 |
Why?
| Cell Count | 3 | 1994 | 163 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 4 | 1981 | 16 |
Why?
| Aldehyde Oxidoreductases | 1 | 1981 | 3 |
Why?
| Phenylacetates | 1 | 1981 | 6 |
Why?
| Nuclear Proteins | 2 | 1995 | 139 |
Why?
| 5' Flanking Region | 1 | 2002 | 6 |
Why?
| Apoptosis | 1 | 2008 | 265 |
Why?
| Humans | 4 | 2005 | 1856 |
Why?
| Stimulation, Chemical | 1 | 2001 | 42 |
Why?
| Injections, Intraventricular | 1 | 2001 | 21 |
Why?
| Calcimycin | 3 | 1986 | 25 |
Why?
| Immunohistochemistry | 2 | 1990 | 355 |
Why?
| Transcription Factor AP-1 | 1 | 2001 | 42 |
Why?
| Membrane Transport Proteins | 1 | 2000 | 43 |
Why?
| Cell Nucleus | 2 | 1999 | 169 |
Why?
| Binding Sites | 2 | 1986 | 213 |
Why?
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1998 | 13 |
Why?
| Cholinergic Antagonists | 1 | 1998 | 5 |
Why?
| Neostriatum | 1 | 1998 | 20 |
Why?
| Nerve Tissue Proteins | 1 | 2000 | 128 |
Why?
| Adaptor Protein Complex 1 | 1 | 1997 | 1 |
Why?
| Adaptor Protein Complex alpha Subunits | 1 | 1997 | 1 |
Why?
| Membrane Glycoproteins | 1 | 2000 | 154 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 1997 | 9 |
Why?
| Immobilization | 1 | 1997 | 27 |
Why?
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 1996 | 2 |
Why?
| Quinuclidinyl Benzilate | 1 | 1996 | 3 |
Why?
| Receptor, Muscarinic M1 | 1 | 1996 | 4 |
Why?
| Phosphatidylinositols | 1 | 1996 | 17 |
Why?
| Up-Regulation | 1 | 1998 | 183 |
Why?
| Adenosine | 1 | 1996 | 57 |
Why?
| Potassium | 3 | 1984 | 98 |
Why?
| Oligonucleotide Probes | 1 | 1995 | 40 |
Why?
| Polymerase Chain Reaction | 1 | 1998 | 279 |
Why?
| Enkephalins | 1 | 1995 | 14 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1995 | 88 |
Why?
| Protein Precursors | 1 | 1995 | 48 |
Why?
| Genes | 1 | 1995 | 82 |
Why?
| Signal Transduction | 2 | 1998 | 313 |
Why?
| Cytological Techniques | 1 | 1994 | 18 |
Why?
| Phenotype | 2 | 2003 | 303 |
Why?
| Cycloheximide | 1 | 1992 | 51 |
Why?
| Ganglia, Sympathetic | 1 | 1992 | 11 |
Why?
| Cell Cycle | 1 | 1994 | 121 |
Why?
| Methamphetamine | 1 | 1992 | 9 |
Why?
| 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone | 2 | 1981 | 1 |
Why?
| Decerebrate State | 1 | 1991 | 8 |
Why?
| Adrenal Cortex | 1 | 1991 | 11 |
Why?
| Parasympatholytics | 1 | 1991 | 10 |
Why?
| Testosterone | 1 | 1992 | 57 |
Why?
| Tegmentum Mesencephali | 1 | 1990 | 9 |
Why?
| Motor Activity | 2 | 2000 | 104 |
Why?
| Actins | 1 | 1991 | 112 |
Why?
| Hippocampus | 2 | 1992 | 83 |
Why?
| Mice, Mutant Strains | 1 | 2009 | 77 |
Why?
| Heterozygote | 1 | 2009 | 80 |
Why?
| Serotonin | 2 | 1992 | 44 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2009 | 26 |
Why?
| Wnt Proteins | 1 | 2009 | 24 |
Why?
| Phosphopyruvate Hydratase | 1 | 2008 | 24 |
Why?
| Carbazoles | 1 | 2008 | 21 |
Why?
| Oxidopamine | 1 | 2008 | 21 |
Why?
| Dependovirus | 1 | 2008 | 29 |
Why?
| DNA Primers | 1 | 2009 | 208 |
Why?
| Indoles | 1 | 2008 | 69 |
Why?
| Phenylethyl Alcohol | 1 | 1986 | 2 |
Why?
| Radioisotope Dilution Technique | 1 | 1987 | 11 |
Why?
| Chromatography | 1 | 1987 | 33 |
Why?
| Chromatography, Ion Exchange | 1 | 1987 | 36 |
Why?
| Hydroxyapatites | 1 | 1987 | 10 |
Why?
| 1-Methyl-3-isobutylxanthine | 1 | 1986 | 6 |
Why?
| Carbon Radioisotopes | 1 | 1987 | 43 |
Why?
| Cholera Toxin | 1 | 1986 | 17 |
Why?
| Tritium | 1 | 1987 | 65 |
Why?
| Phenobarbital | 1 | 1986 | 19 |
Why?
| Sex Factors | 1 | 2009 | 284 |
Why?
| Green Fluorescent Proteins | 1 | 2008 | 105 |
Why?
| Indicators and Reagents | 1 | 1987 | 79 |
Why?
| Durapatite | 1 | 1987 | 25 |
Why?
| Culture Media | 1 | 1986 | 116 |
Why?
| Cytosol | 1 | 1986 | 79 |
Why?
| Peptides | 1 | 2008 | 154 |
Why?
| Bone and Bones | 1 | 2009 | 99 |
Why?
| Microscopy, Electron, Scanning | 1 | 2005 | 69 |
Why?
| Mice, Knockout | 1 | 2009 | 265 |
Why?
| Age Factors | 1 | 2009 | 480 |
Why?
| Enzyme Inhibitors | 1 | 2008 | 216 |
Why?
| MAP Kinase Signaling System | 1 | 2005 | 56 |
Why?
| Bucladesine | 3 | 1986 | 31 |
Why?
| Electrophoresis, Paper | 2 | 1979 | 6 |
Why?
| Tetrachlorodibenzodioxin | 1 | 1986 | 18 |
Why?
| Receptors, Androgen | 1 | 2009 | 29 |
Why?
| Tomography, X-Ray Computed | 1 | 2009 | 321 |
Why?
| Glutamate Decarboxylase | 1 | 2003 | 13 |
Why?
| Disease Models, Animal | 1 | 2008 | 349 |
Why?
| Disease Susceptibility | 1 | 2003 | 61 |
Why?
| Drug Combinations | 1 | 2003 | 95 |
Why?
| Amino Acid Sequence | 1 | 1987 | 319 |
Why?
| Dactinomycin | 1 | 1982 | 40 |
Why?
| Alcohol Oxidoreductases | 1 | 1981 | 6 |
Why?
| Subcellular Fractions | 1 | 1981 | 67 |
Why?
| Neoplasms, Experimental | 1 | 1982 | 72 |
Why?
| Prostaglandins E | 1 | 1981 | 22 |
Why?
| Gliosis | 1 | 2000 | 14 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2000 | 17 |
Why?
| Ventral Tegmental Area | 1 | 2000 | 9 |
Why?
| Injections, Intraperitoneal | 1 | 2000 | 57 |
Why?
| Nucleus Accumbens | 1 | 2000 | 12 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2000 | 37 |
Why?
| Oxidation-Reduction | 1 | 1981 | 124 |
Why?
| Drug Synergism | 1 | 2000 | 104 |
Why?
| Peptide Mapping | 2 | 1987 | 27 |
Why?
| Chromatography, Paper | 1 | 1979 | 17 |
Why?
| Acetaldehyde | 1 | 1979 | 6 |
Why?
| Body Weight | 1 | 2000 | 178 |
Why?
| Catecholamines | 1 | 1999 | 40 |
Why?
| DNA | 1 | 1983 | 262 |
Why?
| RNA | 1 | 1982 | 126 |
Why?
| Carrier Proteins | 1 | 2000 | 177 |
Why?
| Lung | 1 | 2000 | 232 |
Why?
| Orchiectomy | 1 | 1992 | 23 |
Why?
| Body Temperature | 1 | 1992 | 44 |
Why?
| Temperature | 1 | 1992 | 137 |
Why?
| Female | 1 | 2009 | 1643 |
Why?
| Phosphopeptides | 1 | 1987 | 7 |
Why?
| Ionomycin | 1 | 1987 | 12 |
Why?
| Diglycerides | 1 | 1987 | 12 |
Why?
| Ethers | 1 | 1987 | 16 |
Why?
| Calmodulin | 1 | 1986 | 34 |
Why?
| Trypsin | 1 | 1986 | 63 |
Why?
| Phosphates | 1 | 1986 | 71 |
Why?
| Amino Acids | 1 | 1986 | 108 |
Why?
| Osmolar Concentration | 1 | 1984 | 91 |
Why?
| Molecular Weight | 1 | 1984 | 154 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1984 | 167 |
Why?
|
|
Tank's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
